Article info
Review
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions
- Correspondence to Professor Georg Schett, Department of Internal Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, Erlangen 91054, Germany; georg.schett{at}uk-erlangen.de
Citation
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions
Publication history
- Received January 15, 2016
- Revised May 12, 2016
- Accepted May 16, 2016
- First published June 3, 2016.
Online issue publication
July 08, 2016
Article Versions
- Previous version (3 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/